Ocugen Inc (OCGN)
0.9009
-0.02
(-1.92%)
USD |
NASDAQ |
Nov 21, 16:00
0.9008
0.00 (0.00%)
After-Hours: 20:00
Ocugen Profit Margin (Quarterly): -1.14K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.14K% |
| June 30, 2024 | -1.34K% |
| March 31, 2024 | -1.18K% |
| December 31, 2023 | -778.6% |
| September 30, 2023 | -316.8% |
| June 30, 2023 | -4.76K% |
| March 31, 2023 | -3.91K% |
| December 31, 2022 | -1.10K% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -8.40K% |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | -133.3K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-8.40K%
Minimum
Jun 2020
-316.8%
Maximum
Sep 2023
-2.55K%
Average
-1.18K%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
| Cytokinetics Inc | -34.67K% |
| Scholar Rock Holding Corp | -- |
| Mirum Pharmaceuticals Inc | -15.75% |
| SpringWorks Therapeutics Inc | -108.6% |
| NeuroBo Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -136.9% |
| Return on Assets | -87.13% |
| Return on Invested Capital | -127.3% |
| Operating Margin (Quarterly) | -1.17K% |
| Return on Net Operating Assets | -208.4% |